Exact Sciences
EXAS
#1735
Rank
NZ$16.70 B
Marketcap
$90.25
Share price
-0.30%
Change (1 day)
-16.88%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Net assets

Net assets on the balance sheet as of September 2024 : NZ$5.47 Billion

According to Exact Sciences's latest financial reports the company has NZ$5.47 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Exact Sciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$NZ$4.97 B3.77%
2022-12-31$NZ$4.79 B-3.36%
2021-12-31$NZ$4.95 B60.08%
2020-12-31$NZ$3.09 B-8.8%
2019-12-31$NZ$3.39 B234.66%
2018-12-31$NZ$1.01 B38.54%
2017-12-31$NZ$0.73 B51.38%
2016-12-31$NZ$0.48 B1.36%
2015-12-31$NZ$0.47 B29.48%
2014-12-31$NZ$0.36 B123.99%
2013-12-31$NZ$0.16 B37.39%
2012-12-31$NZ$0.11 B12.03%
2011-12-31$NZ$0.10 B3.49%
2010-12-31$NZ$0.10 B1132.11%
2009-12-31$NZ$8.39 M-300.12%
2008-12-31$-NZ$4.2 Million-151.07%
2007-12-31$NZ$8.2 M-61.34%
2006-12-31$NZ$21.23 M-41.06%
2005-12-31$NZ$36.02 M-32.33%
2004-12-31$NZ$53.23 M182.98%
2003-12-31$NZ$18.81 M-74.33%
2002-12-31$NZ$73.27 M-48.4%
2001-12-31$NZ$0.14 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
NZ$1.26 B-76.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.00 B-63.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.49 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$133.47 B 2,337.36%๐Ÿ‡ซ๐Ÿ‡ท France